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Marginal zone (MZ) B cells of the spleen and B1 cells,
termed innate-like B cells, differ from follicular B cells
by their attenuated Ca2+ mobilization, fast antibody
secretion, and increased cell adhesion. We identified
and characterized Mzb1 as an endoplasmic retic-
ulum-localized and B cell-specific protein that was
most abundantly expressed in MZ B and B1 cells.
Knockdown of Mzb1 in MZ B cells increased Ca2+
mobilization and nuclear NFAT transcription factor
localization, but reduced lipopolysaccharide-
induced antibody secretion and integrin-mediated
cell adhesion. Conversely, ectopic expression of an
Lck-Mzb1 transgene in peripheral T cells resulted in
attenuated Ca2+ mobilization and augmented integ-
rin-mediated cell adhesion. In addition to its interac-
tion with the substrate-specific chaperone Grp94,
Mzb1 augmented the function of the oxidoreductase
ERp57 in favoring the expression of integrins in their
activated conformation. Thus, Mzb1 helps to diver-
sify peripheral B cell functions by regulating Ca2+
stores, antibody secretion, and integrin activation.
INTRODUCTION
Peripheral B lymphocytes consist of multiple cell populations
that differ in their phenotype, functional properties, and anatomic
locations (Allman and Pillai, 2008; Hardy et al., 2007; Martin and
Kearney, 2000). In addition to the vast majority of conventional B
cells, also termed follicular B (FoB) cells, which reside in lymph
nodes and in the follicles of the spleen, marginal zone (MZ) B
cells occupy the marginal sinus of the spleen, and B1 cells are
predominantly found in the peritoneal and pleural cavities. MZ
B and B1 cells have been termed ‘‘innate-like B cells,’’ given
that these cells can be stimulated by ligands of Toll-like recep-
tors (TLRs) to quickly differentiate into antibody-secreting cells
that produce ‘‘natural,’’ polyreactive antibodies (Martin and
Kearney, 2000; Rubtsov et al., 2008). Follicular B cells, in
contrast, produce specific antibodies with much slower kineticsIand require stimulation by both B cell receptor (BCR) and TLR for
differentiation into antibody-secreting cells (Richards et al.,
2008). Murine marginal zone B cells have been shown to require
weak BCR signals, whereas strong BCR signaling has been
associated with follicular B cell development (Casola et al.,
2004; Pillai and Cariappa, 2009). B1 cells also differ from
follicular B cells in altered Ca2+ signaling and cell proliferation
(Chumley et al., 2002). In particular, B1 cells display a reduced
Ca2+ mobilization and exist in an ‘‘anergic’’ state in which they
are less responsive to BCR stimulation (Dal Porto et al., 2004;
Wong et al., 2002).
Another distinguishing hallmark of MZ B cells is the abundant
expression of integrins, which helps the anchoring of these cells
to the marginal zone of the spleen (Lu and Cyster, 2002). Integ-
rins are cell-surface receptors composed of alpha- and beta-
chain heterodimers that regulate cell adhesion and cell migration
through bidirectional signaling (Hynes, 2002; Luo et al., 2007;
Moser et al., 2009). Regulation of integrin-mediated cell adhe-
sion depends on conformational changes of integrins, whereby
three distinct states have been defined (Hynes, 2002; Luo
et al., 2007). A bent conformation represents a low-affinity state,
in which integrins have 1/500 and 1/10,000 the affinity for ligand
binding compared to the extended-closed and extended-open
conformations, respectively (Luo et al., 2007). Integrin conforma-
tions have been proposed to depend on long-range disulfide
bonds in the b subunits, and mutations that introduce disulfide
bonds to lock the conformation in the extended or bent states
have been found to alter ligand binding affinity (Lu and Cyster,
2002; Luo et al., 2007).
MZ B cells and B1 cells also differ from FoB cells by their fast
kinetics of antibody secretion in response to lipopolysaccharide
(LPS) stimulation, and B1 cells have been reported to secrete
antibodies spontaneously (Rubtsov et al., 2008). All these
processes depend on functions of the endoplasmic reticulum
(ER), which acts as a major intracellular calcium store and
provides a strongly oxidizing environment that facilitates disul-
fide bond formation and folding of complex glycoproteins,
such as immunoglobulins and integrins (Cahalan, 2009; Todd
et al., 2008; Tu andWeissman, 2004). A family of ER oxidoreduc-
tases, including protein disulfide isomerase (PDI) and ERp57
(PDIA3), allows for the efficient folding of glycoproteins by cata-
lyzing the formation and isomerization of intra- and intermolec-
ular disulfide bonds (Ellgaard and Ruddock, 2005). Oxidativemmunity 33, 723–735, November 24, 2010 ª2010 Elsevier Inc. 723
Figure 1. Mzb1, a MZ B and B1 Cell-Specific ER Protein, Regulates
Cell Proliferation
(A) Immunoblot analysis with a monoclonal Mzb1-specific antibody of total
protein extracts of flow cytometer-sorted primary B cell populations (ASC,
antibody-secreting cells).
(B) Immunoblot analysis of K46 B cell microsomal fractions (Micro) and corre-
sponding supernatants (S100).
(C) Immunoblot analysis of lysates from K46 cells stably transfected with plas-
mids expressing siControl, siMzb1 (clones #2, #29, and #10), siMzb1+
cleavage-resistant Mzb1*, or siMzb1+Mzb1*CXXA.
(D and E) Cell proliferation analysis of siControl-, siMzb1- and siMzb1+Mzb1*-
transfected K46 cells.
(D) [3H] thymidine incorporation was determined in cells without (ø) or with
anti-k stimulation (5 mg/ml) for 16 hr. Data are expressed as the mean [3H]
thymidine incorporation of triplicate cultures and are representative of three
independent experiments. Error bars indicate SD of the mean.
(E) Cell numbers after 12 hr and 72 hr. The data represent mean values of
triplicate cultures and are representative of three independent experiments.
(F) Analysis of tyrosine phosphorylation in serum-deprived and anti-k-stimu-
lated Mzb1-knockdown K46 B cells. Phosphotyrosine-modified proteins
were detected by immunoblot analysis; n = 3.
(G and H) Analysis of cell proliferation of FoB or MZ B cells transduced with
GFP-bicistronic retroviruses expressing Mzb1, siMzb1, or siControl.
(G) Immunoblot analysis for detecting Mzb1 or GAPDH in total cell lysates
(530 mg/lane) of sorted GFP-positive FoB or MZ B cells that were transduced
with Mzb1- or siMzb1-expressing retroviruses.
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chaperones. In particular, ERp57 forms a complex with calnexin
and calreticulin, whereby these lectin chaperones mediate
substrate recognition. The abundant chaperone BiP (Grp78) is
found in a complex with other ER chaperones, such as Grp94
(gp96, Hsp90b1) and PDI (Ni and Lee, 2007). Grp94 has a limited
substrate specificity, which includes integrins, TLRs and immu-
noglobulins, and conditional inactivation of Grp94 in B lympho-
cytes diminished surface expression of TLR and attenuated
secretion of antibodies upon TLR stimulation (Liu and Li, 2008;
Melnick et al., 1994; Randow and Seed, 2001). Given themultiple
phenotypic differences between peripheral B cell subsets, the
question arises as to which genes regulate the characteristic
properties of innate-like B cells. Here, we show that Mzb1, an
ER protein that is abundantly expressed in marginal zone B
and B1 cells, regulates calcium signaling, integrin-mediated
adhesion, and antibody secretion by interacting with ERp57
and forming a substrate-specific complex with the BiP and
Grp94 chaperones. Thus, Mzb1 may help to diversify the func-
tions of peripheral B cell subsets.RESULTS
Mzb1 Regulates Cell Proliferation and BCR
Responsiveness
To identify genes that are differentially expressed in peripheral B
cell subsets, we screened cDNA clones of a pre-B cell minus
erythroid subtractive cDNA library (Travis et al., 1991) for their
expression in FoB cells, MZ B cells, and B1 cells. One clone,
termed Mzb1, was found to be expressed in MZ B and B1 cells
at a substantially higher amount than in FoB cells. We confirmed
the differential expression of Mzb1 by both immunoblot analysis
with an Mzb1 monoclonal antibody and by quantitative RT-PCR
(Figure 1A and Figure S1A available online). By RNA blot
analysis, abundant Mzb1 transcripts could be detected in all
transformed B cell lines examined, regardless of their stage of
differentiation (Figure S1B). Analysis of the tissue distribution of
Mzb1 transcripts indicated that the Mzb1 gene is expressed
predominantly in the spleen and lymph nodes (Figure S1C).
Mzb1 transcripts found in the thymus and lung could be ac-
counted for by contaminating B cells, given that immunoglobulin
k transcripts were also detected. Mzb1 cDNA contains an open
reading frame of 188 amino acids (aa) with marked conservation
from human to the chordate Ciona (Figure S1D). Mzb1 protein
includes a CXXC thioredoxin motif at position 49, a potential
amino-terminal signal sequence and a carboxy-terminal
ER-retrieval sequence. We examined the processing of Mzb1
protein by mass-spectometric analysis and found protein cleav-
ages after amino acids 18 and 20 (Figure S1D and Table S1). Two
recent reports independently described the cloning of Mzb1 as
an ER protein, termed pERp1, which associates with IgM in plas-
macytoma cells (Shimizu et al., 2009; van Anken et al., 2009).
However, no activity was ascribed to pERp1, other than an(H) Analysis of [3H] thymidine incorporation in retrovirally transduced and
GFP-sorted FoB or MZ B cells (mean of triplicate cultures). The data are
representative of three independent experiments and error bars indicate SD
of the mean.
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in plasmacytoma cells.
We determined the subcellular localization of Mzb1 by frac-
tionation of K46 B cells and immunohistochemical analysis of
MZ B cells and NIH 3T3 cells stably transfected with an Mzb1-
GFP gene construct (Figure 1B and Figures S1E and S1F). In
transfected NIH 3T3 cells, the Mzb1-GFP fusion protein, but
not a fusion protein lacking the N-terminal signal sequence,
colocalized with the ER marker Bap31. Moreover, in the micro-
somal fraction of K46 B cells, the endogenous Mzb1 showed
a similar resistance to proteinase-K treatment as the luminal
ER protein BiP, and both proteins were efficiently digested by
proteinase-K in the presence of the detergent Triton X-100 (Fig-
ure 1B). Thus, Mzb1 appears to be localized in the ER lumen.
To gain insight into the function of Mzb1, we generated stably
transfected K46 B cell clones in which the expression of Mzb1
was markedly downregulated by an Mzb1-specific siRNA. As
controls for the specificity of the siRNA-mediated knockdown,
we used both cells carrying a nonspecific siRNA construct and
Mzb1-knockdown cells retransfected with an siRNA-resistant
(Mzb1*) expression construct. Immunoblot analysis with Mzb1
antibody revealed a marked reduction of protein expression in
three independent Mzb1-knockdown clones and an efficient
rescue of Mzb1 protein expression in knockdown cells retrans-
fected with the siRNA-resistant Mzb1* construct (Figure 1C).
The Mzb1-knockdown cells grew more quickly than the
control-knockdown and Mzb1*-rescue cells (Figure 1E). By
determining [H3]-thymidine incorporation, we found that the
unstimulated Mzb1-knockdown clones incorporated 4- to
6-fold more thymidine than control-knockdown cells (Figure 1D).
No marked differences in the apoptosis of untreated or tunica-
mycin-treated Mzb1- and control-knockdown K46 cells were
observed (Figure S1G). BCR stimulation resulted in similar
thymidine incorporation in Mzb1- and control-knockdown cells,
suggesting that Mzb1 may curb the proliferation of K46 B cells
(Figure 1D). To examine whether Mzb1-knockdown results in
activation of K46 cells similar to stimulation by BCR signaling,
we analyzed tyrosine phosphorylation. Immunoblot analysis of
lysates prepared from serum-deprived control-knockdown,
Mzb1-knockdown, and Mzb1*-rescue cells demonstrated that
tyrosine phosphorylation is enhanced in unstimulated Mzb1-
knockdown cells and resembles the pattern observed with
BCR-stimulated control-knockdown cells (Figure 1F). In this
experiment, the stimulation of the BCR further increased tyrosine
phosphorylation, suggesting that Mzb1 may be involved in
setting a threshold for BCR-mediated signaling.
We also examined the effect of Mzb1 downregulation and
Mzb1 overexpression on the proliferation of sorted FoB and
MZ B cells by transduction of primary cells with bicistronic retro-
viruses expressing GFP and Mzb1-specific siRNA or GFP and
Mzb1. To allow for retroviral transduction of FoB cells, we used
anti-CD23, which stimulates them by inducing Ca2+ mobilization
(Kolb et al., 1990). Consistent with anti-CD23-induced Ca2+
mobilization, NFAT2 was detected in the nucleus and cytosol
of these cells (Figure S1H). In contrast, FoB cells purified by
a different scheme, involving depletion of other B cell types
with anti-CD9 (Won and Kearney, 2002), showed a predominant
cytosolic localization of NFAT2 (Figure S1I). Anti-CD23-stimu-
lated and transduced GFP-positive cells were sorted andIanalyzed for Mzb1 expression and cell proliferation (Figures 1G
and 1H and Figure S1J). The transduced lymphocytes kept their
surface phenotype (data not shown). In bothMZB and FoB cells,
the downregulation ofMzb1 increased cell proliferation, whereas
Mzb1 overexpression decreased proliferation. Consistent with
the more abundant Mzb1 expression in MZ B versus FoB cells,
the effects of Mzb1 downregulation were more pronounced in
MZ B cells and those of Mzb1 overexpression were stronger in
FoB cells (Figure 1H). Thus, the downregulation of Mzb1
increased cell proliferation and overall tyrosine phosphorylation,
whereas Mzb1 overexpression decreased the proliferation rate.
Mzb1 Regulates Ca2+ Store Content and Ca2+ Signaling
Ca2+ is a secondmessenger that regulates multiple processes in
immune cells (Vig and Kinet, 2009). In unstimulated cells, a low
cytosolic Ca2+ concentration is maintained by sarcoplasmic-
endoplasmic reticulum calcium ATPase (SERCA)-mediated
pumping of Ca2+ into the ER and by the inactive states of Ca2+
channels. In stimulated cells, Ca2+ release from the ER
stores results in Ca2+ influx and nuclear translocation of the
Ca2+-responsive transcription factor NFAT (Cahalan, 2009;
Crabtree and Olson, 2002). To examine Ca2+ signaling in
response to BCR stimulation, we measured the changes in free
intracellular Ca2+ by flow cytometry. We observed an increase
in stimulated Ca2+ concentrations relative to control-knockdown
and rescue cells in all of the three analyzed clones of Mzb1-
knockdown K46 B cells (Figures 2A and S2A). Complementation
of Mzb1-knockdown cells with gene constructs expressing
siRNA-resistant Mzb1* or Mzb1*CXXA with a mutated CXXA
motif resulted in similar attenuation of Ca2+ signaling (Figures
1C and 2A), suggesting that the function of Mzb1 is independent
of its thioredoxin motif.
We confirmed the enhancement of Ca2+ signaling in Mzb1-
knockdown cells by determining the real-time changes in free
Ca2+ of individual cells (Figure 2B). The altered Ca2+ flux in
BCR-stimulated Mzb1-knockdown cells could be a conse-
quence of changes in the ER Ca2+ store content, an impaired
Ca2+ influx from the cellular environment, or a defect in the
BCR signaling pathway. Because Mzb1 is an ER resident, we
measured potential changes in BCR-independent store-oper-
ated Ca2+ entry by treating cells with thapsigargin, an inhibitor
of the SERCA pump. Thapsigargin treatment of Mzb1-knock-
down and control K46 cells followed by the addition of extracel-
lular Ca2+ showed that Mzb1 downregulation augmented ER
Ca2+ depletion and increased Ca2+ influx (Figure 2C). Treatment
of cells with the ionophore ionomycin in the absence of extracel-
lular Ca2+ resulted in an increased Ca2+ flux in Mzb1-knockdown
cells relative to control and rescue cells, suggesting that Mzb1
regulates the ER Ca2+ store, rather than store-operated Ca2+
entry (Figure S2B). Chemokine signaling also induces Ca2+
fluxes (Muller and Lipp, 2001); however, the effect of the
Mzb1-knockdown onCa2+mobilization was unaffected by expo-
sure to the chemokine CXCL13 prior to triggering of Ca2+ fluxes
(Figures S2C and S2E). Thus, the effect of Mzb1 on Ca2+ mobi-
lization appears to be independent of CXCR5 signaling.
As additional readout of altered Ca2+ fluxes, we analyzed the
effects of Mzb1 downregulation or overexpression on the
nuclear localization and/or activity of the Ca2+-regulated NFATc
transcription factors (Crabtree and Olson, 2002). In K46 B cells,mmunity 33, 723–735, November 24, 2010 ª2010 Elsevier Inc. 725
Figure 2. Mzb1 Expression Decreases the Luminal ER Ca2+ Store Content
(A–C) Analysis of experimentally-induced Ca2+ fluxes in K46 B cells stably transfected with siControl, siMzb1, siMzb1+Mzb1*, and siMzb1+Mzb1*CXXA plasmids.
Indo-1AM-loaded cells were treated (A) with anti-k or (C) thapsigargin and increases in free intracellular Ca2+ were measured in real time. Data are representative
of five independent experiments.
(B) Average [Ca2+]i responses in individual BCR-stimulated siControl-K46 (n = 17) or siMzb1-K46 (n = 7) cells. Error bars indicate SD of the mean.
(D) Indirect immunofluorescence analysis of flow cytometer-sorted GFP-positive mock- or Mzb1-transduced MZ B cells with anti-Mzb1 and anti-NFAT2.
(E) Quantification of the proportion of mock- or Mzb1-transduced GFP-positive FoB cells (n R 120 per genotype) and of siControl- or siMzb1-transduced
GFP-positiveMZB cells (nR 90 per genotype) showing NFAT2 protein distributed over thewhole cell (hatched bar) or concentrated in the cytosolic compartment
(solid bar). GFP served as a marker for transduction and DAPI defined the nuclear area.
(F) Indirect immunofluorescence using siControl- or siMzb1-transduced, GFP-positive FoB cells, as described previously.
(G) Analysis of anti-m induced Ca2+ fluxes in mock- or Mzb1-transduced FoB cells as described above. Data are representative of five independent experiments.
(H) Average [Ca2+]i responses in individual ionomycin-treated NIH 3T3 cells stably transfected with a mock- or Mzb1-expression plasmid.
(I and J) Fluorescence lifetime imaging microscopy (FLIM) to directly determine the ER Ca2+ store content in stably mock- or Mzb1-transfected NIH 3T3
cells transiently transfected with the ER-localized cameleon (YC4.2er). In (I), the phasor plot (right panel) of the FLIM images shown in the two left panels
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Figure 3. Proteomic Analysis of Mzb1-
Associated Proteins
(A) Gel filtration analysis of NP40-solubilized
microsomes of K46 B cells in the absence
(10 mM EDTA) or presence (2.5 mM Ca2+) of
calcium. Mzb1 and Mzb1-containing complexes
in individual fractions were visualized by immuno-
blot analysis for detecting Mzb1, ERp57, and BiP.
(B) In vivo cross-linking and affinity purification of
Mzb1-associated proteins from thapsigargin-
(1 mM) and EGTA- (3mM) treated K46 B cells. After
whole-cell extract preparation and immunoprecip-
itation with anti-Mzb1 or anti-EBNA coupled to
sepharose beads, crosslinks were reversed and
the proteins separated on a 4%–12% SDS-
PAGE gel and visualized by silver stain. Lanes
are from the same gel. Specific bands were cut
out and analyzed by mass-spectrometry with the
protein identities shown. High and low protein
abundance is indicated by plain or italic letters,
respectively.
(C and D) Coimmunoprecipitation analysis of K46
protein extract to detect association of Mzb1
with Grp94, ERp57 and BiP in the (C) absence
(10 mM EDTA) or (D) presence (2.5 mM Ca2+) of
calcium, with anti-Mzb1 antibody for precipitation.
(E) GST-pulldown assay with recombinant Mzb1
protein and glutathione beads coupled to GST,
GST-ERp57, or GST-BiP, followed by an immuno-
blot analysis.
(F) Coimmunoprecipitation analysis of K46 protein
extract for analysis of the association of Mzb1 with
Grp94 and ERp57 in the presence of DTT.
(G) Coimmunoprecipitation analysis of protein
extracts from K46 cells expressing siControl,
siMzb1, and siMzb1+Mzb1* plasmids with
ERp57 antibody for precipitation. Data are repre-
sentative of three independent experiments.
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resulted in enhanced DNA binding by NFAT in electrophoretic
mobility shift assays (Figure S2F) and activation of a luciferase
reporter construct containing multimerized NFAT-binding sites
(Figure S2G). In primary MZ B and B1 cells, Mzb1 downregula-
tion enhanced nuclear localization of NFAT2 (NFATc1) relative
to control siRNA-transduced cells (Figures 2D and 2E and
Figure S2H). Conversely, overexpression of Mzb1 in FoB cells
increased cytosolic localization of NFAT2 (Figures 2E and 2F),
consistent with the reduction of BCR-mediated Ca2+ mobiliza-
tion in Mzb1-overexpressing FoB cells (Figure 2G). Similarly,
a reduced Ca2+ store content, released by ionomycin treatment,
was observed in individual NIH 3T3 fibroblastic cells stably
expressing Mzb1 (Figure 2H).
Finally, we directly measured the Ca2+ store content in indi-
vidual Mzb1-expressing and control NIH 3T3 cells by measuring
the fluorescence lifetime of a transiently transfected ER-local-
ized cameleon Ca2+ indicator (Figures 2I and 2J; Luik et al.,
2008). Mzb1-expressing NIH 3T3 cells showed a significant
decrease in the Ca2+ store content relative to mock-transfectedrepresents the two basic forms of the YC4.2er: one in the absence of Ca2+ havi
binding state that shortens its lifetime (green circle; green pixels in FLIM image).
(J) Representation of the data obtained by the phasor approach as Ca2+ conce
n(NIH 3T3 + Mzb1) = 5 (p = 10
2). Error bars indicate SD of the mean and the signifi
INIH 3T3 cells. Thus, the down- and upregulation of Mzb1 in
primary MZ B and FoB cells result in opposite effects on
experimentally induced Ca2+ fluxes and activation of the
Ca2+-responsive NFAT transcription factors. Taken together,
these data indicate that Mzb1 regulates Ca2+ signaling via
modulating the ER Ca2+ store content.
Proteomic Analysis of Mzb1-Associated Proteins
To identify potential Mzb1 interaction partners, we performed
a gel filtration experiment with the microsomal fraction of K46
B cells. Immunoblot analysis of individual fractions indicated
that the majority of Mzb1 is found in fractions corresponding to
25 kDa, whereas a small amount of Mzb1 was detected in higher
molecular weight fractions of 220 kDa (Figure 3A). The higher
molecular weight complex of Mzb1 was sensitive to changes in
Ca2+ concentration, given that its abundance was decreased
by the addition of 2.5 mM Ca2+. We crosslinked proteins
in vivo to stabilize interactions prior to cell lysis and purified the
Mzb1-associated proteins by precipitation with anti-Mzb1. The
immunoprecipitates were separated by SDS-PAGE, and gelng a long lifetime (red circle; red pixels in FLIM image) and one in the calcium
ntrations with the ‘‘Globals for Images’’ software with n(NIH 3T3 mock) = 4 and
cance was determined by a two-tailed t test.
mmunity 33, 723–735, November 24, 2010 ª2010 Elsevier Inc. 727
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from the anti-Mzb1 and the anti-EBNA isotype control lanes (Fig-
ure 3B). Mass spectrometry of the eluted proteins allowed for the
identification of the chaperones Grp94 and BiP, as well as the
protein disulfide isomerases ERp57 and PDIA6 (CaBP1) as
Mzb1-associated proteins (Figure 3B and Table S2). In the
anti-Mzb1 lane, we also detected a lower abundance of peptides
derived from SERCA2b, a client protein of ERp57 (Li and Cama-
cho, 2004), and integrin b1, a client protein of ERp57 and Grp94
(Yang and Li, 2005).
To confirm the associations of Mzb1 with the identified protein
partners, we coimmunoprecipitated Mzb1 protein complexes
from K46 B cell extracts in the absence and presence of Ca2+.
Both Grp94, a protein with high-affinity binding sites for Ca2+,
and ERp57 interact with their client proteins at highCa2+ concen-
trations (Biswas et al., 2007; Li and Camacho, 2004). However,
Grp94, ERp57, and BiP were efficiently coimmunoprecipitated
with anti-Mzb1 in the absence of Ca2+ and less efficiently in
the presence of 2.5 mM Ca2+, suggesting that these proteins
associate with Mzb1 in a calcium-dependent manner (Figures
3C and 3D). These interactions were also detected by coimuno-
precipitations with antibodies against ERp57 and Grp94 (Figures
S3A and S3B). Moreover, reprobing the immunoblot of the gel
filtration experiments described above revealed an overlap of
the 220 kDa Mzb1 complex with ERp57 at low but not high
Ca2+ concentrations (Figure 3A). In GST pull-down assays,
recombinant Mzb1 interacted with both GST-BiP and
GST-ERp57, but not with GST alone (Figure 3E). Addition of
10 mM DTT to a K46 cell lysate impaired coimmunoprecipitation
of ERp57 andMzb1, but not that of Grp94 andMzb1, suggesting
that the association of Mzb1 and ERp57 involves disulfide bonds
(Figure 3F). Finally, we analyzed whether the association ofMzb1
with ERp57 competes for the interaction of ERp57 with calnexin
and calreticulin. In coimmunoprecipitations with anti-ERp57, we
detected abundant amounts of calnexin and calreticulin in
lysates from siMzb1-knockdown cells, but not in lysates from
control-knockdown and Mzb1*-rescue cells. Conversely, we
observed coimmunoprecipitation of both Mzb1 and Grp94 in
lysates from control-knockdown and Mzb1*-rescue cells (Fig-
ure 3G). These data suggest that the interaction of Mzb1 with
ERp57 results in an exchange of ERp57-associated chaperones.
Mzb1 Regulates Antibody Secretion in LPS-Stimulated
MZ B Cells
MZ B cells differ from FoB cells by their fast kinetics of antibody
secretion, and therefore we examined whether Mzb1 downregu-
lation or Mzb1 overexpression in sorted MZ B and FoB cells
alters LPS-induced antibody secretion. ELISpot analysis of
Mzb1 siRNA-expressing MZ B cells showed 1/7 the number
of ASCs relative to control siRNA-expressing MZ B cells (Fig-
ure 4A). Conversely, retroviral Mzb1 overexpression in FoB cells
stimulated with anti-CD23 and suboptimal concentrations of
LPS resulted in a 5-fold increase in the number of ASCs relative
to mock-transduced cells. Moreover, overexpression of Mzb1 in
MZ B cells increased the number of ASCs, whereas the downre-
gulation of Mzb1 in FoB cells decreased the frequency of ASCs
(Figure 4B). In ELISA assays, we detected an50% decrease of
IgM secretion in Mzb1-knockdown MZ B cells and a two-fold
increase in Mzb1-overexpressing FoB cells, relative to control728 Immunity 33, 723–735, November 24, 2010 ª2010 Elsevier Inc.cells (Figure S4). Flow cytometry analysis to detect CD138,
a marker of ASCs (Tumang et al., 2005), indicated that only a
minor fraction of LPS-stimulated andGFP-positive cells differen-
tiated to CD138-positive cells (Figure 4C).
The function of TLR4, which transduces LPS signals, is
altered in Grp94-deficient cells (Randow and Seed, 2001), and
therefore we examined the surface expression of TLR4 and the
transcriptional response to LPS. Mzb1-knockdown cells contain
modestly reduced numbers of TLR4 molecules on the cell
surface (Figure 4D). Quantitative RT-PCR analysis of MZ B cells
transduced with Mzb1- or control-siRNA revealed reduced
amounts of both uninduced and induced transcription of the
NF-kB-regulated genes Ccl22 and Bcl2a1a (encoding A1) in
Mzb1-knockdown cells (Figure 4E; Genestier et al., 2007;
Ghadially et al., 2005). As a control, transcription of the Bcl2l1
(encoding Bcl-xL) gene was not affected. Therefore, Mzb1 regu-
lates the secretion of antibodies in LPS-stimulated MZ B cells,
but not the transcriptional response to LPS stimulation.
Mzb1 Regulates Cell Motility and the Activation
of Integrins
A hallmark of MZ B cells is the abundant surface expression of
aLb2 (LFA-1), a4b7, and a4b1 (VLA-4) integrins, which allow
for their sessile, non-recirculatory state (Lu and Cyster, 2002).
Moreover, these integrins are regulated by chemokine-medi-
ated, inside-out signaling (Kinashi, 2005). Static adhesion assays
indicated that unstimulated control siRNA-transduced MZ B
cells displayed moderate adhesion to the LFA-1 ligand ICAM-1
and the VLA-4 ligand VCAM-1, which could be markedly
increased by treatment of cells with the chemokines CXCL13
or CXCL12. In Mzb1-knockdown MZ B cells, we observed
a pronounced decrease in adhesion to ICAM-1 and VCAM-1 in
the absence of chemokines, which was further enhanced by
the addition of CXCL12 or CXCL13 (Figure 5A). This decrease
in integrin-mediated adhesion in Mzb1-knockdown MZ B cells
was confirmed by the reduced ability of these cells to bind
soluble ICAM-1 or VCAM-1, as determined by flow cytometry
(Figures 5B and 5C; Sebzda et al., 2002).
Finally, we examined the functional status of LFA-1 and VLA-4
on Mzb1-knockdown MZ B cells by analyzing their chemotactic
response to CXCL13 on transwell filters coated with ICAM-1 or
VCAM-1 (Ansel et al., 2002; Lu and Cyster, 2002). In Mzb1-
knockdown cells, we observed an increase in the CXCL13-medi-
ated migration relative to control-knockdown cells, reflecting
a decreased adhesion ability of these cells (Figure 5D). No
obvious differences in the migration of Mzb1- and control-
knockdown MZ B cells were detected on BSA-coated transwell
filters. Likewise, integrin-mediated adhesion of Mzb1-knock-
down K46 B cells was found to be reduced relative to control
and Mzb1*-rescue cells (Figure 5E). The surface expression of
the CXCL13 receptor, CXCR5, was not altered on transduced
MZ B and K46 B cells (Figures S5A and S5B). Moreover, we de-
tected a reduced surface expression of integrin aLb2 (LFA-1),
which was comparable to that of freshly isolated FoB cells
(Figures 6A and 6B). However, the total and surface expression
of integrin b1 was similar in Mzb1-siRNA- and control-trans-
duced MZ B cells (Figures 6C and 6D and Figure S6A), raising
the question of whether the activation of integrins may be
impaired in Mzb1-knockdown cells.
Figure 4. Mzb1 Influences Antibody Secre-
tion
(A and B) ELISpot-analysis to detect IgM antibody-
secreting cells in MZ B and FoB cells transduced
with a control- or Mzb1-siRNA-expressing retro-
virus or with a mock- or Mzb1-expressing retro-
virus. Retroviral transductions were performed
for 48 hr, whereby LPS (1 mg/ml) was added after
36 hr and GFP-positive cells were sorted and stim-
ulated with LPS (1 mg/ml) for an additional 4 hr.
Data represent the mean and SD of triplicate
samples and data are representative of three inde-
pendent experiments.
(C) Flow cytometric analysis of GFP expression
and surface CD138 levels on MZ B cells trans-
duced with a Mzb1-siRNA-expressing retrovirus
(left panels) and on FoB cells transduced with
a Mzb1-expressing retrovirus (right panels). Cells
were either infected in the absence of LPS (upper
four panels) or infected for 24 hr in the absence of
LPS and then stimulated with 1 mg/ml of LPS for
24 hr (lower two panels). Flow cytometry dot plots
reflect living B220-positive cells with the B220-
gate shown in the two histograms. The solid gray
line represents the isotype control (two upper
panels) and data are representative of three
independent experiments.
(D) Flow cytometric analysis of surface TLR4 on
siControl- or siMzb1-expressing MZ B cells. The
solid gray line represents the isotype control and
FACS profiles reflect living, GFP-positive cells.
(E) Quantitative RT-PCR analysis of Ccl22,
Bcl2a1a, and Bcl2l1 transcripts in siControl- or
siMzb1-MZB cells. GFP-positive cells were sorted
and left untreated or stimulated with LPS (1 mg/ml)
for 24 hr. Relative expression is normalized to actin
(n = 3).
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extended structure that reflect differences in the ligand-binding
affinities (Luo et al., 2007; Moser et al., 2009). The extended
conformation of integrins, which represents the high-affinity
receptor, results in a localized ‘‘unfolding’’ of the ectodomain
that can be detected by activation state-specific antibodies
(Bazzoni et al., 1995). Flow cytometry analysis to detect the
extended form of b1 revealed a decrease in the expression of
the high-affinity form of VLA-4 in Mzb1-knockdown MZ B cells
(Figures 6D). Moreover, lysates from Mzb1-knockdown K46 B
cells contained reduced amounts of extended b1 integrin (Fig-
ure 6E), consistent with the diminished surface expression on
these cells (Figure S6B).
Because ERp57 is involved in the efficient folding of integrins
(Jessop et al., 2009), we investigated potential effects of Mzb1
on the isomerization of disulfide bonds in b1 integrin, by using
an in vitro folding assay. We added recombinant Mzb1, alone
or in combination with ERp57 or BiP as a control, to recombinant
VLA-4 in which the disulfide bonds were partially reduced with
DTT. Analysis of the conformation of VLA-4 by immunoprecipita-
tion with an activation state-specific anti-b1, followed by immu-
noblot analysis for b1 integrin detection, indicated that Mzb1
augmented the activity of ERp57 in generating extended b1 in-
tegrin (Figures 6F and 6G). However, Mzb1 did not enhanceIthe oxidative folding activity of ERp57 with insulin as a substrate
(Figure 6H and Figure S6C). Thus, Mzb1 regulates activity of
ERp57 on specific substrates.
Lck-Mzb1 Transgenic T Cells Show Altered Ca2+
Mobilization and Cell Adhesion
To examine whether or not Mzb1 can confer alteration of Ca2+
mobilization and cell adhesion upon non-B cells in vivo, we
generated transgenic mice carrying an Mzb1 gene under the
control of the Lck-promoter (Garvin et al., 1990). We confirmed
that Mzb1 is not expressed in T cells. With the exception of
thymic DN1 stage T cell precursors, none of the other examined
T cell populations expressed Mzb1 protein at a detectable level
(Figure 7A). Two of three independent transgenic lines ex-
pressed Mzb1 at abundant amounts in CD4+ and CD8+ T cells
of thymus, lymph node, and spleen (Figure 7B). Analysis of
CD4+ and CD8+ T cells by flow cytometry indicated that the
ectopic expression of Mzb1 resulted in a modest reduction
(20%) of T cell numbers in lymph nodes and spleen, but did
not affect the proportions of the analyzed T cell populations
(data not shown). However, stimulation of Mzb1-transgenic
CD4+ and CD8+ T cells with anti-CD33 and anti-CD28 revealed
a decreased incorporation of [H3]-thymidine relative to T cells
from wild-type littermates (Figure 7C and Figure S7A). Likewise,mmunity 33, 723–735, November 24, 2010 ª2010 Elsevier Inc. 729
Figure 5. Mzb1 Regulates Integrin-Medi-
ated Cell Adhesion
(A) Static adhesion to ICAM-1 or VCAM-1. SiCon-
trol- or siMzb1-MZ B cells were treated with buffer
(ø) or stimulated with CXCL13 or CXCL12. Assays
were performed in triplicate, and data are repre-
sentative of three independent experiments. Error
bars indicate SD of the mean.
(B and C) LFA-1 and VLA-4 affinity assays with
siControl- or siMzb1-MZ B cells. The histograms
show the relative ability of untreated (ø) or
CXCL13-stimulated, GFP-positive MZ B cells to
bind soluble (B) ICAM-1-Fc or (C) VCAM-1-Fc.
(D) Chemotaxis assay of siControl- or siMzb1-MZ
B cells. GFP-positive cells were placed in trans-
well chambers coated with ICAM-1, VCAM-1, or
BSA and allowed to migrate toward CXCL13.
Assays were performed in duplicate, and data
are representative of at least three independent
experiments. Error bars indicate SD of the mean.
(E) Chemotaxis assay of siControl-, siMzb1-, and
siMzb1+Mzb1*-K46 cells as described in (D).
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Regulation of Peripheral B Cell Functions by Mzb1TCR-induced Ca2+ mobilization was reduced in mature T cells
of two Mzb1-transgenic lines relative to T cells of a wild-type
littermate (Figures 7D and7E and Figures S7B and S7C). We
also observed an impaired nuclear localization of NFAT2 in
Mzb1-transgenic CD4+ and CD8+ T cells that have been
stimulated with anti-CD33 and anti-CD28 (Figure 7F and Fig-
ures S7D–S7F; Crabtree and Olson, 2002). Finally, we examined730 Immunity 33, 723–735, November 24, 2010 ª2010 Elsevier Inc.LFA-1-mediated adhesion in Mzb1-
transgenic CD4+ and CD8+ T cells by
static adhesion assays in the presence
or absence of CXCL12. In unstimulated
wild-type T cells, a moderate adhesion
to the LFA-1 ligand ICAM-1 was
observed, which could be increased by
treatment of cells with CXCL12. However,
in Mzb1-expressing T cells, we observed
an increase in adhesion to ICAM-1 in the
absence or presence of CXCL12 (Fig-
ure 7G and Figure S7G). Moreover, we
detected a modestly increased surface
expression of LFA-1 (Figure 7H and
Figure S7H). Taken together, these
data suggest that the expression of
Mzb1 is sufficient to confer changes in
Ca2+ mobilization and integrin-mediated
cell adhesion.
DISCUSSION
Our analysis of Mzb1 indicates that this
cell-type-specific luminal ER protein
regulates at least three functions of
peripheral B cells. First, Mzb1 controls
Ca2+ homeostasis and the ER Ca2+ store,
as evidenced by the enhanced ER Ca2+
depletion and extracellular Ca2+ influx
in thapsigargin-stimulated Mzb1-knock-down K46 B cells. A converse effect on Ca2+ fluxes was
observed in Mzb1-overexpressing FoB cells and NIH 3T3 cells,
as well as in Mzb1-transgenic T cells. The altered Ca2+ homeo-
stasis in cells in which Mzb1 has been down- or upregulated
could be accounted for by the interaction of Mzb1 with the
SERCA pump and one of its regulators, the oxidoreductase
ERp57 (Li and Camacho, 2004). The regulation of the ER Ca2+
Figure 6. Mzb1 Regulates Integrin Folding
by Substrate-Specific Enhancement of
ERp57 Activity
(A and B) Flow cytometric analysis of aL and b2
surface integrin expression on (A) siControl- or
siMzb1-MZ B cells and on (B) untreated FoB or
MZ B cells. The solid gray line represents the
isotype control, and FACS profiles reflect living
or living and GFP-positive cells.
(C) Immunoblot analysis to detect expression of
integrin chains in cell lysates of siControl- or
siMzb1-MZ B cells.
(D) Flow cytometric analysis of surface integrin
exression of either pan-b1 integrin or its extended
form on siControl- or siMzb1-MZ B cells. FACS
profiles reflect living, GFP-positive cells, and
data are representative of three independent
experiments. The solid gray line represents the
isotype control.
(E) Coimmunoprecipitation analysis of protein
extracts from K46 cells expressing siControl,
siMzb1, or siMzb1+Mzb1* using a pan-b1 integ-
rin-specific or a b1 extended form-specific anti-
body for precipitation.
(F and G) Thiol-dependent catalytic activity of
GST-ERp57, BiP, Mzb1 and GST-ERp57 com-
bined with Mzb1 was measured using a VLA-4
folding assay. Human recombinant VLA-4 was
incubated with the indicated proteins and the
reduced and extended form of b1 integrin was
immunoprecipitated. The precipitated protein
was detected with a pan-b1 antibody. Densito-
metric analysis of the intensity of the b1 integrin-
specific immunoblot signal, quantified by the
AlphaEaseFC (AlphaImager 3400) software is
presented in (G).
(H) Enzymatic activity of GST-ERp57, GST-BiP,
Mzb1, and GST-ERp57 combined with Mzb1 was
measured using the insulin turbidity assay. GST-
BiP alone and an input sample lacking enzyme
(control) are used as negative controls in this
assay. AbsorbanceOD650nm values were collected
and plotted as a function of time, and the enzy-
matic activity was calculated (DAbsOD650nm/min)
(n = 3). Error bars indicate SD of the mean.
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Regulation of Peripheral B Cell Functions by Mzb1store by Mzb1 is probably related to the effects of altered Mzb1
expression on the nuclear localization of NFAT2, which is modu-
lated by the Ca2+ and calmodulin-dependent serine-threonine
phosphatase calcineurin (Crabtree and Olson, 2002). Knock-
down of Mzb1 in MZ B and B1 cells enhanced nuclear localiza-
tion of NFAT2, whereas overexpression of Mzb1 in FoB cells or
transgenic T cells impaired nuclear localization of NFAT2.
Changes in Ca2+ signaling and NFAT activity have been attrib-
uted to the proliferative response of B cells. In particular,
NFAT2-deficient mice show a compromised B cell proliferation
in vitro (Ranger et al., 1998). Likewise, the mutation of the regu-
latory subunit of calcineurin in B cells results in a cell-autono-
mous defect in cell proliferation (Winslow et al., 2006). In primary
MZ B cells and in K46 B cells, the knockdown of Mzb1 increased
cell proliferation, whereas the overexpression of Mzb1 in FoBIcells decreased cell proliferation and BCR-mediated Ca2+ mobi-
lization, suggesting that Mzb1 sets a threshold for Ca2+
signaling. Peripheral B cell subsets differ in their cellular
responses to BCR signaling (Casola et al., 2004). The Mzb1-
mediated changes of the homeostatic ER Ca2+ concentration
are consistent with the anergic state of B1 cells and the weak
signal dependence of MZ B cells (Dal Porto et al., 2004; Pillai
and Cariappa, 2009). Therefore, Mzb1 may indirectly contribute
to cell-type-specific differences in BCR signal transduction.
Second, Mzb1 affects the secretion of antibodies in LPS-stim-
ulated B lymphocytes, but not the transcriptional response to
LPS. Moreover, LPS-stimulated FoB cells upregulate Mzb1
expression with kinetics that resemble that of antibody secretion
(data not shown), and the forced expression of Mzb1 in FoB cells
accelerates and augments immunoglobulin secretion. Themmunity 33, 723–735, November 24, 2010 ª2010 Elsevier Inc. 731
Figure 7. Ectopic Expression of Mzb1 in T
Cells Alters Ca2+ Mobilization and Cell-
Adhesion
(A) Immunoblot analysis to detect Mzb1 in protein
extracts of FACS-sorted primary thymic T cell
populations.
(B) Immunoblot analysis to detect Mzb1 in lysates
from primary T cell populations derived from wild-
type (wt) or Lck-Mzb1 transgenic mice (lines #3
and #7).
(C) Analysis of cell proliferation of CD4+ spleno-
cytes from wild-type or Lck-Mzb1 transgenic
mice by determining [3H] thymidine incorporation
in cells without (ø) or with stimulation by anti-
CD33 (1 mg/ml) and anti-CD28 (1 mg/ml) for 16 hr.
Data are expressed as the mean [3H] thymidine
incorporation of triplicate cultures and are repre-
sentative of three independent experiments. Error
bars indicate SD of the mean.
(D and E) Analysis of TCR-induced Ca2+ fluxes
of CD4+ splenocytes from wild-type or Lck-Mzb1
transgenic mice (lines #3 and #7 shown in D
and E, respectively) as described above. Data
are representative of four independent experi-
ments.
(F) Indirect immunofluorescence analysis of
FACS-sorted and anti-CD33 (10 mg/ml) plus anti-
CD28 (5 mg/ml) stimulated wild-type or Mzb1-
transgenic CD4+ T cells (line #3) with anti-Mzb1
and anti-NFAT2 antibodies.
(G) Static adhesion assay to ICAM-1. Wild-type or
Mzb1-transgenic CD4+ T cells were treated with
buffer (ø) or stimulated with CXCL12. Assays
were performed in triplicate, and data are repre-
sentative of three independent experiments. Error
bars indicate SD of the mean.
(H) Flow cytometric analysis of aL and b2 surface
integrin levels on wild-type or Mzb1-transgenic
CD4+ T cells (lines #3 and #7). The gray line repre-
sents the isotype control and data are representa-
tive of three independent experiments.
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cells has at most a 2-fold effect on antibody secretion (van Anken
et al., 2009) suggests that the effect of Mzb1 on immunoglobulin
secretionmay be restricted to stimulation via TLRs and/or limited
to primary cells. The observed changes in antibody secretion in
Mzb1-knockdown cells may be accounted for by the association
of Mzb1 with ERp57 and Grp94. Moreover, in Mzb1-knockdown
MZ B cells, TLR4 surface expression is downregulated, raising
the possibility that the impaired antibody secretion could
reflect a combined defect in TLR surface expression and
immunoglobulin folding.
Third, Mzb1 has a role in the integrin-mediated adhesion ofMZ
B cells and T cells. We find that downregulation of Mzb1 in MZ B
cells impairs the chemokine-induced adhesion to the integrin
ligands VCAM-1 or ICAM-1. Conversely, ectopic expression of
Mzb1 in T cells is sufficient for increasing integrin-mediated732 Immunity 33, 723–735, November 24, 2010 ª2010 Elsevier Inc.cell adhesion. Interestingly, a major
function of Mzb1 in regulating the activity
of integrins is the transition of the bent
conformation to the extended conforma-tion, which has been shown to represent the activation-compe-
tent state (Hynes, 2002; Luo et al., 2007). In addition, we observe
changes in the surface expression of the integrins aL and b2. The
marked effect of Mzb1 downregulation on the activation of
integrins appears to be related to the association of Mzb1 with
ERp57. Notably, we find that Mzb1 augments the oxidoreduc-
tase activity of ERp57 on integrin b1 in vitro, but does not
enhance its activity on insulin, suggesting that Mzb1 confers
substrate specificity upon ERp57.
How can Mzb1 affect multiple cellular processes? Mzb1 has
no structural hallmarks besides a CXXC thioredoxin motif.
However, we could not detect any marked oxidoreductase
activity of Mzb1 by itself in vitro, and mutation of one cysteine
of the CXXC motif had no pronounced effect on the function of
Mzb1 in regulating Ca2+ signaling. The interaction partner of
Mzb1, ERp57, exists in a complex with calreticulin and calnexin
Immunity
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recognition (Appenzeller-Herzog and Ellgaard, 2008; Jessop
et al., 2009). However, the mass spectrometric analysis of
Mzb1-associated proteins suggested that Mzb1 interacts with
the Grp94-BiP multichaperone complex and ERp57 in the
absence of the calreticulin and calnexin chaperones. Moreover,
an exchange of the ERp57-associated chaperones by Mzb1 is
supported by the coimmunoprecipitation of calnexin and calreti-
culin with ERp57 antibody in Mzb1-knockdown cells, whereas
Grp94 is preferentially coimmunoprecipitated in control and
Mzb1*-rescue cells.
Various biological processes have been shown to depend on
both ERp57 and Grp94. MHC class I assembly requires both
proteins, and the enzymatic activity of ERp57 undergoes a
transient change upon covalent linkage with tapasin (Wearsch
and Cresswell, 2008). In this context, ERp57 acts in concert
with tapasin, independently of its partners calreticulin and
calnexin. Moreover, both ERp57 and Grp94 regulate ER Ca2+
homeostasis. Althoughmultiple ER proteins have a high capacity
for Ca2+ binding, Grp94 appears to have a unique effect on the
ER Ca2+ store. In particular, Grp94-deficient but not calreticu-
lin-deficient cells are hypersensitive to perturbations in Ca2+
stores (Biswas et al., 2007). The specific effect of Grp94 on
Ca2+ homeostasis has been interpreted to suggest that Grp94
physically or functionally interacts with Ca2+ pumps, Ca2+
leakage channels, or a regulatory protein. Mzb1 may regulate
the recruitment of Grp94 and ERp57 to SERCA2b, which was
also identified in our proteomic analysis. The association of
Mzb1 with ERp57 and SERCA2b may also explain why Mzb1
has negative roles in Ca2+ fluxes and cell proliferation, whereas
it has a positive role in integrin activation and antibody secretion.
ERp57 has been shown to inhibit the activity of SERCA2b by in-
teracting with its intraluminal loop L4 (Li and Camacho, 2004).
Moreover, overexpression of ERp57 reduces the frequency of
SERCA2b-dependent Ca2+ oscillations in Xenopus oocytes
and overexpression of SERCA2b variants with mutated
cysteines located in loop L4 increases the frequency of Ca2+
oscillation. In this context, ERp57 does not affect the activity of
SERCA2b mutants lacking the calreticulin-binding site (Li and
Camacho, 2004).
If the function of Mzb1 involves the association with ERp57
and Grp94 in vivo, one might expect some overlap of pheno-
types observed in B cells with altered Mzb1, ERp57, or Grp94
expression. TLR-stimulated, Grp94-deficient B cells display an
attenuated antibody production, whereby the defect has been
attributed to a diminished surface expression of TLR (Liu and
Li, 2008). Moreover, Grp94-deficient B cells show a selective
loss of the surface expression of a4 and aL integrins (Liu and
Li, 2008; Randow and Seed, 2001), consistent with the effects
of Mzb1 downregulation on integrin expression and function.
ERp57-deficient B cells show a defect in antigen presentation
but have no major phenotype in cell proliferation or antibody
secretion (Garbi et al., 2006). However, this study did not
examine a potential role of ERp57 in ‘‘innate-like’’ B cells and in-
tegrin function. The association of Mzb1 with components of
a multichaperone complex is also intriguing in light of the ability
of chaperone proteins to promote rapid changes in phenotypic
traits and to allow selection to act on multiple processes at
one time (Rutherford, 2003). Therefore, Mzb1 may have beenIinvolved in diversifying the immune functions of peripheral B
cell subsets.
EXPERIMENTAL PROCEDURES
Mzb1 Knockdown and Retroviral Transduction
siRNA duplexes were designed using the Invitrogen BLOCK-iT program.
Mzb1-specific duplex 50-GCGAAAGCAGAGGCUAAAU-30 and a scrambled
control siRNA duplex 50-GUACCUUGACAGUACCGAU-30 were cloned into
the pSuper RNAi system (OligoEngine). Stable clones for both siRNA duplexes
were generated, and the siRNA clone revealing the most efficient Mzb1-
knockdown clone (clone #10) was stably transfected with either a siRNA-resis-
tant Mzb1 cDNA (Mzb1*) or a mutated, siRNA-resistant Mzb1 cDNA, carrying
a cysteine to alanine mutation at position 52 (Mzb1*CXXA). For knockdown of
Mzb1 in FACS-sorted B220+CD21hiCD23 MZ B, B220+CD21intCD23hi FoB
or peritoneal CD19+CD5+CD23 B1 B cells (FACS antibodies acquired from
BD Biosciences), the Mzb1-specific siRNA duplex and the scrambled control
siRNA duplex were integrated into a modified version of the GFP bicistronic
pEGZ-MCS retroviral vector and the GP+E86 packaging cell line was trans-
fected with the retroviral reporter plasmids (Markowitz et al., 1988). For infec-
tion of MZ B, FoB, or B1 B cells, mitomycin C-inactivated GP+E86 packaging
cells were plated to confluency on gelatinized cell culture plates and the
lymphocytes were cocultured with the inactivated GP+E86 feeders in RPMI
1640 media supplemented with polybrene (2 mg/ml) at 5% CO2 and 37
C for
48 hr. After infection, GFP-positive lymphocytes were enriched. For overex-
pression of Mzb1 in FoB or MZ B cells, Mzb1 cDNA was cloned into the
GFP bicistronic pEGZ/MCS retroviral vector and the cells were transduced
as described above.
Transwell Assay
Chemotaxis assays of siControl- and siMzb1-MZ B cells or siControl-,
siMzb1-, and siMzb1+Mzb1*-transfected K46 cells to CXCL13 (R&D Systems)
were performed as described (Lu and Cyster, 2002). In brief, transduced MZ B
cells or K46 B cells were enriched for GFP-positive cells and resuspended in
RPMI 1640 media for primary lymphocytes, and 1 3 105 cells (per well) were
placed in 5 mm (MZ) or 8 mm (K46) transwell chemotaxis chambers (Corning
Costar). The chambers were coated for 1 hr with BSA (0.25% in PBS),
ICAM-1 (3 mg/ml in PBS; R&D Systems), or VCAM-1 (3 mg/ml in PBS; R&D
Systems), washed two times with 0.1% BSA in RPMI 1640, and blocked
with 0.5% BSA in RPMI 1640. Cells were incubated in the coated chambers
for 3 hr at 37C and 5% CO2. Cells that migrated to the lower chamber, con-
taining 0, 0.1 or 0.5 mg/ml CXCL13, were counted by collecting events for
a fixed time (60 s) on a FACS Calibur flow cytometer.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures and two tables, and can be found with this article online at
doi:10.1016/j.immuni.2010.11.013.
ACKNOWLEDGMENTS
We thank I. Falk for expert technical help, A. Travis for the initial screening of
the cDNA library, B. Schreiber and M. Pink for their help in generating the
siRNA knockdown cells, K. Rattay for help in establishing the isomerization
assay and E. Kremmer (GSF, Munich) for producing Mzb1 monoclonal anti-
bodies. We thank M. Digman and E. Gratton for assistance with the fluores-
cence lifetime imaging measurements. We are grateful to R. Faessler, S. Ro-
spert, A. Spang, H.P. Hauri, W. Schamel and M. Reth for discussions and
advice. We thank R. Faessler, U. Hartl and E. Mandel for comments on the
manuscript. S.K. was supported by a Danish Graduate Student Fellowship.
This work was supported by funds of the Max-Planck-Research-Society.
Received: December 23, 2009
Revised: July 20, 2010
Accepted: September 20, 2010
Published online: November 18, 2010mmunity 33, 723–735, November 24, 2010 ª2010 Elsevier Inc. 733
Immunity
Regulation of Peripheral B Cell Functions by Mzb1REFERENCES
Allman, D., and Pillai, S. (2008). Peripheral B cell subsets. Curr. Opin. Immunol.
20, 149–157.
Ansel, K.M., Harris, R.B., and Cyster, J.G. (2002). CXCL13 is required for B1
cell homing, natural antibody production, and body cavity immunity.
Immunity 16, 67–76.
Appenzeller-Herzog, C., and Ellgaard, L. (2008). The human PDI family:
Versatility packed into a single fold. Biochim. Biophys. Acta 1783, 535–548.
Bazzoni, G., Shih, D.T., Buck, C.A., and Hemler, M.E. (1995). Monoclonal anti-
body 9EG7 defines a novel beta 1 integrin epitope induced by soluble ligand
and manganese, but inhibited by calcium. J. Biol. Chem. 270, 25570–25577.
Biswas, C., Ostrovsky, O., Makarewich, C.A., Wanderling, S., Gidalevitz, T.,
and Argon, Y. (2007). The peptide-binding activity of GRP94 is regulated by
calcium. Biochem. J. 405, 233–241.
Cahalan, M.D. (2009). STIMulating store-operated Ca(2+) entry. Nat. Cell Biol.
11, 669–677.
Casola, S., Otipoby, K.L., Alimzhanov, M., Humme, S., Uyttersprot, N., Kutok,
J.L., Carroll, M.C., and Rajewsky, K. (2004). B cell receptor signal strength
determines B cell fate. Nat. Immunol. 5, 317–327.
Chumley, M.J., Dal Porto, J.M., and Cambier, J.C. (2002). The unique antigen
receptor signaling phenotype of B-1 cells is influenced by locale but induced
by antigen. J. Immunol. 169, 1735–1743.
Crabtree, G.R., and Olson, E.N. (2002). NFAT signaling: Choreographing the
social lives of cells. Cell Suppl. 109, S67–S79.
Dal Porto, J.M., Burke, K., and Cambier, J.C. (2004). Regulation of BCR signal
transduction in B-1 cells requires the expression of the Src family kinase Lck.
Immunity 21, 443–453.
Ellgaard, L., and Ruddock, L.W. (2005). The human protein disulphide isom-
erase family: Substrate interactions and functional properties. EMBO Rep. 6,
28–32.
Garbi, N., Tanaka, S., Momburg, F., and Hammerling, G.J. (2006). Impaired
assembly of the major histocompatibility complex class I peptide-loading
complex in mice deficient in the oxidoreductase ERp57. Nat. Immunol. 7,
93–102.
Garvin, A.M., Abraham, K.M., Forbush, K.A., Farr, A.G., Davison, B.L., and
Perlmutter, R.M. (1990). Disruption of thymocyte development and lymphoma-
genesis induced by SV40 T-antigen. Int. Immunol. 2, 173–180.
Genestier, L., Taillardet, M., Mondiere, P., Gheit, H., Bella, C., and Defrance, T.
(2007). TLR agonists selectively promote terminal plasma cell differentiation of
B cell subsets specialized in thymus-independent responses. J. Immunol. 178,
7779–7786.
Ghadially, H., Ross, X.L., Kerst, C., Dong, J., Reske-Kunz, A.B., and Ross, R.
(2005). Differential regulation of CCL22 gene expression in murine dendritic
cells and B cells. J. Immunol. 174, 5620–5629.
Hardy, R.R., Kincade, P.W., and Dorshkind, K. (2007). The protean nature of
cells in the B lymphocyte lineage. Immunity 26, 703–714.
Hynes, R.O. (2002). Integrins: Bidirectional, allosteric signaling machines. Cell
110, 673–687.
Jessop, C.E., Tavender, T.J., Watkins, R.H., Chambers, J.E., and Bulleid, N.J.
(2009). Substrate specificity of the oxidoreductase ERp57 is determined
primarily by its interaction with calnexin and calreticulin. J. Biol. Chem. 284,
2194–2202.
Kinashi, T. (2005). Intracellular signalling controlling integrin activation in
lymphocytes. Nat. Rev. Immunol. 5, 546–559.
Kolb, J.P., Renard, D., Dugas, B., Genot, E., Petit-Koskas, E., Sarfati, M.,
Delespesse, G., and Poggioli, J. (1990). Monoclonal anti-CD23 antibodies
induce a rise in [Ca2+]i and polyphosphoinositide hydrolysis in human acti-
vated B cells. Involvement of a Gp protein. J. Immunol. 145, 429–437.
Li, Y., and Camacho, P. (2004). Ca2+-dependent redox modulation of SERCA
2b by ERp57. J. Cell Biol. 164, 35–46.734 Immunity 33, 723–735, November 24, 2010 ª2010 Elsevier Inc.Liu, B., and Li, Z. (2008). Endoplasmic reticulum HSP90b1 (gp96, grp94)
optimizes B-cell function via chaperoning integrin and TLR but not immuno-
globulin. Blood 112, 1223–1230.
Lu, T.T., and Cyster, J.G. (2002). Integrin-mediated long-term B cell retention
in the splenic marginal zone. Science 297, 409–412.
Luik, R.M., Wang, B., Prakriya, M., Wu, M.M., and Lewis, R.S. (2008).
Oligomerization of STIM1 couples ER calcium depletion to CRAC channel
activation. Nature 454, 538–542.
Luo, B.H., Carman, C.V., and Springer, T.A. (2007). Structural basis of integrin
regulation and signaling. Annu. Rev. Immunol. 25, 619–647.
Markowitz, D., Goff, S., and Bank, A. (1988). A safe packaging line for
gene transfer: Separating viral genes on two different plasmids. J. Virol. 62,
1120–1124.
Martin, F., and Kearney, J.F. (2000). B-cell subsets and the mature preimmune
repertoire. Marginal zone and B1 B cells as part of a ‘‘natural immune
memory’’. Immunol. Rev. 175, 70–79.
Melnick, J., Dul, J.L., and Argon, Y. (1994). Sequential interaction of the
chaperones BiP and GRP94 with immunoglobulin chains in the endoplasmic
reticulum. Nature 370, 373–375.
Moser, M., Legate, K.R., Zent, R., and Fassler, R. (2009). The tail of integrins,
talin, and kindlins. Science 324, 895–899.
Muller, G., and Lipp, M. (2001). Signal transduction by the chemokine receptor
CXCR5: Structural requirements for G protein activation analyzed by chimeric
CXCR1/CXCR5 molecules. Biol. Chem. 382, 1387–1397.
Ni, M., and Lee, A.S. (2007). ER chaperones in mammalian development and
human diseases. FEBS Lett. 581, 3641–3651.
Pillai, S., and Cariappa, A. (2009). The follicular versus marginal zone B
lymphocyte cell fate decision. Nat. Rev. Immunol. 9, 767–777.
Randow, F., and Seed, B. (2001). Endoplasmic reticulum chaperone gp96 is
required for innate immunity but not cell viability. Nat. Cell Biol. 3, 891–896.
Ranger, A.M., Hodge, M.R., Gravallese, E.M., Oukka, M., Davidson, L., Alt,
F.W., de la Brousse, F.C., Hoey, T., Grusby, M., and Glimcher, L.H. (1998).
Delayed lymphoid repopulation with defects in IL-4-driven responses
produced by inactivation of NF-ATc. Immunity 8, 125–134.
Richards, S., Watanabe, C., Santos, L., Craxton, A., and Clark, E.A. (2008).
Regulation of B-cell entry into the cell cycle. Immunol. Rev. 224, 183–200.
Rubtsov, A.V., Swanson, C.L., Troy, S., Strauch, P., Pelanda, R., and Torres,
R.M. (2008). TLR agonists promote marginal zone B cell activation and
facilitate T-dependent IgM responses. J. Immunol. 180, 3882–3888.
Rutherford, S.L. (2003). Between genotype and phenotype: Protein chaper-
ones and evolvability. Nat. Rev. Genet. 4, 263–274.
Sebzda, E., Bracke, M., Tugal, T., Hogg, N., and Cantrell, D.A. (2002). Rap1A
positively regulates T cells via integrin activation rather than inhibiting
lymphocyte signaling. Nat. Immunol. 3, 251–258.
Shimizu, Y., Meunier, L., and Hendershot, L.M. (2009). pERp1 is significantly
up-regulated during plasma cell differentiation and contributes to the oxidative
folding of immunoglobulin. Proc. Natl. Acad. Sci. USA 106, 17013–17018.
Todd, D.J., Lee, A.H., and Glimcher, L.H. (2008). The endoplasmic reticulum
stress response in immunity and autoimmunity. Nat. Rev. Immunol. 8,
663–674.
Travis, A., Amsterdam, A., Belanger, C., and Grosschedl, R. (1991). LEF-1,
a gene encoding a lymphoid-specific protein with an HMG domain, regulates
T-cell receptor alpha enhancer function. Genes Dev. 5, 880–894.
Tu, B.P., and Weissman, J.S. (2004). Oxidative protein folding in eukaryotes:
Mechanisms and consequences. J. Cell Biol. 164, 341–346.
Tumang, J.R., Frances, R., Yeo, S.G., and Rothstein, T.L. (2005).
Spontaneously Ig-secreting B-1 cells violate the accepted paradigm for
expression of differentiation-associated transcription factors. J. Immunol.
174, 3173–3177.
vanAnken, E., Pena, F., Hafkemeijer, N., Christis, C., Romijn, E.P., Grauschopf,
U., Oorschot, V.M., Pertel, T., Engels, S., Ora, A., et al. (2009). Efficient IgM
assembly and secretion require theplasmacell induced endoplasmic reticulum
protein pERp1. Proc. Natl. Acad. Sci. USA 106, 17019–17024.
Immunity
Regulation of Peripheral B Cell Functions by Mzb1Vig, M., and Kinet, J.P. (2009). Calcium signaling in immune cells. Nat.
Immunol. 10, 21–27.
Wearsch, P.A., and Cresswell, P. (2008). The quality control of MHC class I
peptide loading. Curr. Opin. Cell Biol. 20, 624–631.
Winslow, M.M., Gallo, E.M., Neilson, J.R., and Crabtree, G.R. (2006). The
calcineurin phosphatase complex modulates immunogenic B cell responses.
Immunity 24, 141–152.IWon, W.J., and Kearney, J.F. (2002). CD9 is a unique marker for marginal zone
B cells, B1 cells, and plasma cells in mice. J. Immunol. 168, 5605–5611.
Wong, S.C., Chew, W.K., Tan, J.E., Melendez, A.J., Francis, F., and Lam, K.P.
(2002). Peritoneal CD5+B-1 cells have signaling properties similar to tolerant B
cells. J. Biol. Chem. 277, 30707–30715.
Yang, Y., and Li, Z. (2005). Roles of heat shock protein gp96 in the ER quality
control: Redundant or unique function? Mol. Cells 20, 173–182.mmunity 33, 723–735, November 24, 2010 ª2010 Elsevier Inc. 735
